These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 7878603

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
    Bui-Xuan B, Aupetit JF, Freysz M, Faucon G, Timour Q.
    Pharmacotherapy; 1997; 17(4):737-45. PubMed ID: 9250551
    [Abstract] [Full Text] [Related]

  • 4. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
    Bui-Xuan B, Aupetit JF, Freysz M, Loufoua-Moundanga J, Faucon G, Timour Q.
    Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
    Timour Q, Freysz M, Aupetit JF, Loufoua J, Frassati D, Faucon G.
    Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study.
    Vaillant F, Timour Q, Descotes J, Manati W, Belhani D, Bui-Xuan B, Tabib A, Bricca G, Chevalier P.
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):548-54. PubMed ID: 19034029
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of antiarrhythmic drugs on the repetitive extrasystole threshold and the ventricular fibrillation threshold.
    Murakawa Y, Toda I, Nozaki A, Kawakubo K, Sugimoto T.
    Cardiology; 1989 Dec; 76(1):58-66. PubMed ID: 2468414
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M, Kinukawa M, Kanazawa T, Maruyama K, Miyagi M, Miyata H, Ujiie A.
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [Abstract] [Full Text] [Related]

  • 19. Effects of flecainide on atrial and ventricular stimulation thresholds to repetitive extrasystoles and fibrillation and on "2nd Phase" ventricular arrhythmias in dogs.
    Heuer H, Gülker H, Thale J, Bender F.
    Arzneimittelforschung; 1983 Nov; 33(12):1651-4. PubMed ID: 6199033
    [Abstract] [Full Text] [Related]

  • 20. The cutaneous analgesic effect of class I antiarrhythmic drugs.
    Tzeng JI, Cheng KI, Huang KL, Chen YW, Chu KS, Chu CC, Wang JJ.
    Anesth Analg; 2007 Apr; 104(4):955-8. PubMed ID: 17377113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.